Cytokinetics (CYTK) Assets Average (2016 - 2024)
Historic Assets Average for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $1.5 billion.
- Cytokinetics' Assets Average rose 9466.11% to $1.5 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.5 billion, marking a year-over-year increase of 9466.11%. This contributed to the annual value of $919.5 million for FY2023, which is 91.61% down from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Assets Average is $1.5 billion, which was up 9466.11% from $1.2 billion recorded in Q2 2024.
- In the past 5 years, Cytokinetics' Assets Average registered a high of $1.5 billion during Q3 2024, and its lowest value of $244.5 million during Q2 2020.
- In the last 5 years, Cytokinetics' Assets Average had a median value of $814.0 million in 2022 and averaged $760.8 million.
- In the last 5 years, Cytokinetics' Assets Average soared by 13337.1% in 2021 and then crashed by 2514.93% in 2023.
- Quarter analysis of 5 years shows Cytokinetics' Assets Average stood at $504.0 million in 2020, then surged by 65.58% to $834.4 million in 2021, then rose by 25.28% to $1.0 billion in 2022, then dropped by 25.15% to $782.5 million in 2023, then soared by 89.14% to $1.5 billion in 2024.
- Its Assets Average stands at $1.5 billion for Q3 2024, versus $1.2 billion for Q2 2024 and $816.2 million for Q1 2024.